21-hydroxylase deficiency differential diagnosis: Difference between revisions
(Undo revision 1333071 by Mehrian.jafari (talk)) |
|||
Line 80: | Line 80: | ||
|- | |- | ||
|Gestational [[hyperandrogenism]] | |Gestational [[hyperandrogenism]] | ||
| | | colspan="2" | | ||
* Maternal serum [[androgen]] concentrations (usually [[testosterone]] and [[androstenedione]]) are high | * Maternal serum [[androgen]] concentrations (usually [[testosterone]] and [[androstenedione]]) are high | ||
* If [[virilization]] is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic [[steroid]] not measured in assays for [[testosterone]] or other [[androgens]] | * If [[virilization]] is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic [[steroid]] not measured in assays for [[testosterone]] or other [[androgens]] | ||
| | | | ||
* [[Androgen]] excess sign and symptoms in mother | * [[Androgen]] excess sign and symptoms in mother | ||
Line 136: | Line 135: | ||
* Low [[testosterone]] levels | * Low [[testosterone]] levels | ||
| | | | ||
* Salt-wasting adrenal | * Salt-wasting [[adrenal crisis]] in infancy | ||
* Mild [[virilization]] of genetically female infants | * Mild [[virilization]] of genetically female infants | ||
* Undervirilization of genetically male infants, making it the only form of [[CAH]] which can cause [[ambiguous genitalia]] in both genetic sexes. | * [[Undervirilization]] of genetically male infants, making it the only form of [[CAH]] which can cause [[ambiguous genitalia]] in both genetic sexes. | ||
|- | |- | ||
|[[Polycystic ovary syndrome ]] | |[[Polycystic ovary syndrome ]] | ||
Line 146: | Line 146: | ||
* Low [[testosterone]] levels | * Low [[testosterone]] levels | ||
| | | | ||
* Polycystic ovaries in sonography | * [[Polycystic ovaries]] in sonography | ||
* [[Obesity]] | * [[Obesity]] | ||
* [[PCOS]] is the most common cause of [[hirsutism]] in women | * [[PCOS]] is the most common cause of [[hirsutism]] in women | ||
Line 176: | Line 176: | ||
* Variable [[mineralocorticoid]] excess | * Variable [[mineralocorticoid]] excess | ||
| | | | ||
* Cushingoid | * [[Cushingoid appearance]] | ||
|- | |- | ||
|[[Hyperprolactinemia]] | |[[Hyperprolactinemia]] | ||
Line 184: | Line 184: | ||
* Increased [[prolactin]] | * Increased [[prolactin]] | ||
| | | | ||
* [[Infertility]], [[ | * [[Infertility]], [[galactorrhea]] | ||
|} | |} | ||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 15:17, 1 August 2017
21-hydroxylase deficiency Microchapters |
Differentiating 21-Hydroxylase Deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency differential diagnosis On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency differential diagnosis |
21-hydroxylase deficiency differential diagnosis in the news |
Risk calculators and risk factors for 21-hydroxylase deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Mehrian Jafarizade, M.D [2]
Overview
21-hydroxylase deficiency must be differentiated from 11-β hydroxylase deficiency, 17-α hydroxylase deficiency, androgen insensitivity syndrome, 3β-Hydroxysteroid Dehydrogenase, polycystic ovarian syndrome, hyperprolactinemia, cushing syndrome, and adrenal tumor.
Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency classic type must be differentiated from diseases that cause ambiguous genitalia:[1][2]
Disease name | Laboratory tests | Important clinical findings | |
---|---|---|---|
Increased | Decreased | ||
Classic type of 21-hydroxylase deficiency |
|
| |
11-β hydroxylase deficiency |
|
| |
17-α hydroxylase deficiency |
| ||
3β-Hydroxysteroid Dehydrogenase |
| ||
Gestational hyperandrogenism |
|
|
21-hydroxylase deficiency Non-classic type must be differentiated from diseases that cause virilization and hirsutism in female:[3][2][4]
Disease name | Steroid status | Other laboratory | Important clinical findings |
---|---|---|---|
Non-classic type of 21-hydroxylase deficiency | Increased:
response to ACTH |
|
|
11-β hydroxylase deficiency | Increased:
Decreased: |
|
|
3β-Hydroxysteroid Dehydrogenase | Increased:
Decreased: |
|
|
Polycystic ovary syndrome |
|
|
|
Adrenal tumors |
|
|
|
Ovarian virilizing tumor |
|
|
|
Cushing's syndrome |
|
||
Hyperprolactinemia |
|
|
References
- ↑ Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT (2007). "Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development". Best Pract. Res. Clin. Endocrinol. Metab. 21 (3): 351–65. doi:10.1016/j.beem.2007.06.003. PMID 17875484.
- ↑ 2.0 2.1 White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.
- ↑ Hohl A, Ronsoni MF, Oliveira M (2014). "Hirsutism: diagnosis and treatment". Arq Bras Endocrinol Metabol. 58 (2): 97–107. PMID 24830586. Vancouver style error: initials (help)
- ↑ Melmed, Shlomo (2016). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 978-0323297387.=